ELIANA trial

The ELIANA trial is a clinical study that focused on treating patients, particularly children and young adults, with a type of blood cancer called acute lymphoblastic leukemia (ALL). It investigated an innovative treatment known as CAR T-cell therapy, where doctors modify a patient's own immune cells to better fight cancer. The trial aimed to evaluate the safety and effectiveness of this therapy, providing promising results that could improve outcomes for those with difficult-to-treat leukemia. The findings contribute to the growing field of personalized cancer treatments, offering hope to patients with limited options.